1. Home
  2. ONMD vs FLNA Comparison

ONMD vs FLNA Comparison

Compare ONMD & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

N/A

Current Price

$5.36

Market Cap

31.3M

Sector

N/A

ML Signal

N/A

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$0.44

Market Cap

30.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
FLNA
Founded
2006
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
30.0M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
ONMD
FLNA
Price
$5.36
$0.44
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $6.50
AVG Volume (30 Days)
25.8K
★ 358.7K
Earning Date
11-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 83.33
N/A
EPS
★ N/A
N/A
Revenue
$1,359,000.00
★ $41,119,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 111.35
N/A
52 Week Low
$0.63
$0.43
52 Week High
$115.00
$2.03

Technical Indicators

Market Signals
Indicator
ONMD
FLNA
Relative Strength Index (RSI) 41.05 29.61
Support Level $3.86 N/A
Resistance Level $39.25 $0.68
Average True Range (ATR) 0.52 0.05
MACD 0.75 -0.01
Stochastic Oscillator 59.81 9.70

Price Performance

Historical Comparison
ONMD
FLNA

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: